CASI Pharmaceuticals CASIF Ratios (2021-2026)

OTC CASIF
$0.10 +0.00 (+0.05%)
As of: Oct 21, 2026 · 10:56 AM EDT
Reported Financials

CASI Pharmaceuticals Quarterly Ratios

Periods 18 quarters
Latest Jun 2026

CASI Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 18 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Profitability
Gross Margin 58.77%58.75%58.42%71.72%59.53%59.41%58.72%59.05%52.98%51.95%51.91%24.17%58.00%49.29%22.96%51.14%
EBT Margin -77.09%-74.75%-55.98%-97.70%-86.41%-95.16%-57.65%-49.85%-273.48%-217.49%-106.78%-95.72%-165.10%-265.39%-346.89%-1,068.82%
EBIT Margin -77.09%-74.75%-55.98%-97.70%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Operating Margin -77.09%-74.75%-55.98%-97.70%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Net Margin -99.87%-108.00%-59.49%-178.41%-79.98%-106.50%-59.23%-109.08%-276.68%-182.99%-108.34%-109.88%-172.28%-320.65%-354.93%-1,157.31%
Efficiency
Inventory AverageInventory Avg. 7.35M8.17M8.30M12.37M15.66M15.02M4.70M3.78M3.00M2.10M1.72M
Assets AverageAssets Avg. 92.32M83.14M76.05M74.75M66.64M54.64M47.25M36.01M27.83M25.06M23.36M
Equity AverageEquity Avg. 42.08M35.90M30.51M26.48M19.82M12.24M-3.11M-14.19M-24.45M-32.94M-47.77M
Invested CapitalInvested Cap. 43.06M34.05M27.49M20.24M-17.09M-37.01M
Asset Utilization RatioAsset Util. 0.460.530.560.450.430.420.660.880.960.83
Leverage & Solvency
Debt Ratio 0.250.320.360.340.791.01
Valuation
Price to SalesP/S 0.560.740.770.812.831.673.193.741.541.070.580.960.84
Price to BookP/B 1.320.540.791.041.203.963.128.1623.69
Enterprise Value 86.72M113.24M39.98M36.35M-2.13M12.16M18.50M21.87M66.69M30.07M64.05M82.41M30.38M22.57M11.54M21.03M11.84M-0.27M
Market Capitalization 111.84M113.24M39.98M36.35M24.09M31.22M33.64M34.45M95.79M48.30M73.58M82.41M43.84M33.46M18.28M25.72M17.47M3.49M
Return Ratios
Return on Sales [ROS]ROS -77.09%-74.75%-55.98%-97.70%-86.41%-95.16%-57.65%-49.85%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Return on Capital Employed [ROCE]ROCE -43.80%-52.29%-57.02%-43.22%-47.03%-59.40%-299.58%
Return on Assets [ROA]ROA -40.88%-46.85%-46.60%-35.13%-45.11%-45.92%-86.84%-130.89%-178.24%-475.40%
Return on Equity [ROE]ROE -89.69%-108.49%-116.15%-99.17%-151.69%-204.93%

CASI Pharmaceuticals Ratios API

Pull CASI Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CASIF&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY